Physician profile
Neil B Pollack
NPI 1831189802
$903.04
in general payments reported to CMS, 2019-2025
17 companies · $76.93 in 2025
The $76.93 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2020: $31.48 · 2021: $19.08 · 2022: $77.30 · 2023: $133 · 2024: $150 · 2025: $76.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $198.20 | 2019-2025 | Thinprep 2000 Processor, Aptima, Affirm Prone Biopsy System |
| Abbvie INC. | $156.83 | 2019-2021 | |
| Pfizer INC. | $143.96 | 2019-2024 | |
| Therapeuticsmd, INC. | $61.36 | 2019 | |
| Amag Pharmaceuticals, INC. | $54.51 | 2019-2020 | |
| Baxter Healthcare | $46.39 | 2019-2024 | Tisseel |
| Coopersurgical, INC. | $41.81 | 2019-2023 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $34.58 | 2019-2023 | |
| Covidien LP | $23.20 | 2019 | |
| Glaxosmithkline, LLC. | $21.52 | 2024 | Shingrix, Arexvy |
| Mayne Pharma Commercial LLC | $20.06 | 2024 | |
| Exeltis, USA INC. | $19.68 | 2023 | Slynd |
| Mylan Pharmaceuticals INC. | $17.62 | 2022 | |
| Myovant Sciences INC. | $17.21 | 2022 | |
| Astellas Pharma US INC | $16.49 | 2023 | Veozah |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.00 | 2023 | Spevigo |
| Vertical Pharmaceuticals, LLC | $14.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Pollack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.